Stocks of G Medical Innovations Holdings Ltd (NASDAQ:GMVD) traded higher last session on Wall Street, up 40.84% to $2.69.
GMVD stock price is now -5.76% away from the 50-day moving average and -68.94% away from the 200-day moving average. The market capitalization of the company currently stands at $3.83M.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
.
A total of 66.81% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in GMVD stock. A new stake in G Medical Innovations Holdings Ltd shares was purchased by UBS GROUP AG during the first quarter worth $4,000. BANK OF AMERICA CORP /DE/ invested $2,000 in shares of GMVD during the first quarter. In total, there are 14 active investors with 2.58% ownership of the company’s stock.
Wednesday’s opening bell rang with an opening price of $1.9500 for G Medical Innovations Holdings Ltd (NASDAQ: GMVD). During the past 12 months, G Medical Innovations Holdings Ltd has had a low of $1.66 and a high of $57.05. The fifty day moving average price for GMVD is $2.8391 and a two-hundred day moving average price translates $8.6152 for the stock.
The latest earnings results from G Medical Innovations Holdings Ltd (NASDAQ: GMVD) was released for Jun, 2022.
G Medical Innovations Holdings Ltd(GMVD) Company Profile
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company’s products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.
